Company Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Business Summary
Number of employees: 579
Managers
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 03/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 26/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 26/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 03/01/21 |
Director/Board Member | 59 | 21/10/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 97,235,316 | 46,097,791 ( 47.41 %) | 0 | 47.41 % |
Company contact information
Myovant Sciences Ltd.
11-12 St. James?s Square Suite 1, 3rd Floor
SW1Y 4LB, London
+
http://www.myovant.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |